Pulmatrix, Inc.
PULM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574235
No open-market purchases or sales by Pulmatrix, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $568.7K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Pulmatrix, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −1 vs. Q2 2021
- Shares held
- 7.68M
- −284.3K (−3.6%) vs. Q2 2021
- Total value
- $6.14M
- −$2.14M (−25.8%) vs. Q2 2021
- New holders
- 3
- 5 more added
- Sold out
- 4
- 6 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PULM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $568.7K |
| Q1 2026 | 15 | $425.1K |
| Q4 2025 | 15 | $795.4K |
| Q3 2025 | 14 | $1.68M |
| Q2 2025 | 12 | $2.31M |
| Q1 2025 | 11 | $2.10M |
| Q4 2024 | 11 | $2.26M |
| Q3 2024 | 13 | $566.2K |
| Q2 2024 | 12 | $485.6K |
| Q1 2024 | 14 | $433.5K |
| Q4 2023 | 12 | $565.5K |
| Q3 2023 | 12 | $776.6K |
| Q2 2023 | 14 | $1.14M |
| Q1 2023 | 16 | $1.50M |
| Q4 2022 | 14 | $2.25M |
| Q3 2022 | 13 | $2.04M |
| Q2 2022 | 16 | $2.71M |
| Q1 2022 | 14 | $3.69M |
| Q4 2021 | 24 | $5.36M |
| Q3 2021 | 20 | $6.14M |
| Q2 2021 | 22 | $8.28M |
| Q1 2021 | 28 | $9.42M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Pulmatrix, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 2,693,157 | $2.15M | 0.00% | −155,234−5.4% | Reduced |
| Vanguard Group Inc | 2,047,588 | $1.64M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,246,148 | $997.0K | 0.00% | −18,399−1.5% | Reduced |
| Geode Capital Management, LLC | 504,183 | $403.0K | 0.00% | +16,184+3.3% | Added |
| Polaris Venture Management Co. V, L.L.C. | 359,441 | $288.0K | 2.04% | 00.0% | Unchanged |
| State Street Corp | 278,923 | $223.0K | 0.00% | +2,100+0.8% | Added |
| Morgan Stanley | 117,911 | $94.0K | 0.00% | −147,537−55.6% | Reduced |
| Northern Trust Corp | 107,007 | $86.0K | 0.00% | 00.0% | Unchanged |
| Parallax Volatility Advisers, L.P. | 97,919 | $78.0K | 0.00% | 00.0% | Unchanged |
| Winton Group Ltd | 61,588 | $49.0K | 0.00% | +3,856+6.7% | Added |
| First Republic Investment Management, Inc. | 50,000 | $40.0K | 0.00% | +40,000+400.0% | Added |
| Citadel Advisors LLC | 42,557 | $34.0K | 0.00% | +42,557 | New |
| UBS Group AG | 21,900 | $18.0K | 0.00% | −12,718−36.7% | Reduced |
| Two Sigma Advisers, LP | 20,200 | $16.0K | 0.00% | +20,200 | New |
| Two Sigma Securities, LLC | 13,786 | $11.0K | 0.00% | +13,786 | New |
| Cambridge Investment Research Advisors, Inc. | 10,197 | $8.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 5,000 | $4.00K | 0.00% | +3,000+150.0% | Added |
| Bank of America Corp | 1,197 | $1.00K | 0.00% | −258−17.7% | Reduced |
| American Portfolios Advisors | 1,200 | $960 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 327 | $0 | 0.00% | −17−4.9% | Reduced |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −58,081−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,064−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −14,608−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |